HALO logo
halo search icon
GH Research Plc
GH Research Plc
GHRS · NAS

GH Research Plc

US$22.54

Price Arrow0.60 (2.74%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumHALO MomentumHALO Price Momentum+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

GH Research Plc Overview

GHRS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About GHRS

icon

Website

GH Research Plc

icon

Telephone

353.1.437.8334

icon

Address

Dawson Street, Joshua Dawson House, Dublin 2

Description

GH Research Plc is a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients with psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.

GHRS Price Chart

Key Stats

Market Cap

US$1.50B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 10.66 - 24.66

Trade Value (12mth)

US$1,099,960.00

1 week

2.57%

1 month

6.25%

YTD

65.71%

1 year

86.09%

All time high

30.43

Key Fundamentals

EPS 3 yr Growth

83.10%

EBITDA Margin

0.00%

Operating Cashflow

-$44m

Free Cash Flow Return

-19.00%

ROIC

-21.00%

Interest Coverage

-130.30

Quick Ratio

34.10

Other Data

Shares Outstanding (Fully Diluted)

62m

HALO Sector

Healthcare

Next Company Report Date

04-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

GHRS Announcements

Latest Announcements

DateAnnouncements
15 May 26
14 May 26
14 May 26
14 May 26
14 May 26

GHRS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.68-0.75-0.79locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.68-0.75-0.79locklocklock
Growth
%locklocklocklock-58.5-9.5-5.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of GH Research Plc (GHRS:NAS)?
Halo FAQ
The current share price of GH Research Plc (GHRS:NAS) is USD$22.54.
What is the 52-week high share price for GH Research Plc (GHRS:NAS)?
Halo FAQ
The 52-week high share price for GH Research Plc (GHRS:NAS) is USD$24.66.
What is the 52-week low share price for GH Research Plc (GHRS:NAS)?
Halo FAQ
The 52-week low share price for GH Research Plc (GHRS:NAS) is USD$10.66.
What is the dividend yield for GH Research Plc (GHRS:NAS)?
Halo FAQ
GH Research Plc (GHRS:NAS) does not pay a dividend.
What was GH Research Plc (GHRS:NAS) last dividend payment?
Halo FAQ
GH Research Plc (GHRS:NAS) does not pay a dividend.
What is the franking level for GH Research Plc (GHRS:NAS)?
Halo FAQ
GH Research Plc (GHRS:NAS) has a franking level of 0.00%.
In which sector is GH Research Plc (GHRS:NAS) classified?
Halo FAQ
GH Research Plc (GHRS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.